Ann: Entitlement Offer - Extension of Closing Date, page-22

First 22 Last

Share
Profile

Follow
Outgoing123

859 Posts.

53

05/04/23

14:20

Post #: 67149961
Share

Originally posted by ainsleym: ↑

Who knows. I'd be interested to see if Siemens Health participates in some form or another with $, maybe picking up some of the shortfall as a placement if the SPP if the SPP is not fully taken up. Siemens has been in some form of technical liaison with IBX from the commencement of the clinical trials ( but management have never spelt out to us what the detail of this liaison is, .. why , one could reasonably ask). Siemens have a significant global interest in medical imaging diagnostics so their interest is understandable. Will that ever turn into some kind of financial support is a fair question especially given the recent confirmation that the nano particles are improving imaging contrast. If Siemens came to the party with $$ and, importantly, had a management/oversight role in further trials then its a different ball game to what we have now , and a potential game changer. But as it currently stands with our management team I find it hard to be overly positive in progressing this technology to commercialization in a reasonable timeframe.

Expand

"Siemens has been in some form of technical liaison with IBX from the commencement of the clinical trials ( but management have never spelt out to us what the detail of this liaison is, .. why , one could reasonably ask). Siemens have a significant global interest in medical imaging diagnostics so their interest is understandable."

I am not sure why Siemens will have "more" interests than 12 months ago.
Siemens might get advantage if we develop MRX (with help of Siemens), then Siemens may get a sort of "exclusive" rights.
But now IBX is focusing on MRI, this will always works on MRI machines include Siemens, GE, Philips,..etc.
Why would Siemens spend fortunes on IBX?

IBX Price at posting: 1.7¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply